Pankaj Mishra, PhD’s Post

View profile for Pankaj Mishra, PhD

Founder & CTO - Future Therapeutics | Building proprietary AI infrastructure to find new cures | Co-founder - Neovarsity

A new company called Xaira Therapeutics just launched with over $1B+ billion in funding for using AI in drug discovery R&D. To give you some context, the last time we saw this level of fundraising was for Roivant Sciences, which focuses on creating companies around abandoned drugs, and Altos Labs, with $3B for cellular rejuvenation programming. But this is the 1st for an AI drug discovery R&D company. Interestingly, a significant portion of the company's technology originates from the Institute for Protein Design at the University of Washington, which is renowned for its work in protein science. This institute is led by Prof. David Baker, the co-founder of this and also the Charm Therapeutics. Read the full story here: https://lnkd.in/eCZfV4CW #drugdiscovery #artificialintelligence

In biggest-ever bet on using AI to design drugs, biotech heavyweights launch Xaira with $1B+ in backing

In biggest-ever bet on using AI to design drugs, biotech heavyweights launch Xaira with $1B+ in backing

https://endpts.com

Bushra Alam

Postdoctoral Research Fellow | Quantum and Computational Chemist | Electronic Structure Theory

10mo

It would be interesting to know the actual correlation between startup funding, and successful new drug candidates discovered in 5-10 years.

Like
Reply

To view or add a comment, sign in

Explore topics